VINC: Vincerx Pharma to dissolve, with minimal or no distributions expected for stockholders

Vincerx Pharma is dissolving after failing to secure capital, with Q1 2025 net loss at $5.0M and cash expected to run out by Q3 2025. No distributions to stockholders are expected, and all operations are winding down.

Original document: Vincerx Pharma, Inc. [VINC] SEC 10-Q Quarterly Report — May. 14 2025